找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Breast Cancer; A Guide to Clinical Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019 Springer Nature Switzerland AG 2019 breast disease.c

[复制链接]
楼主: foresight
发表于 2025-3-25 06:51:00 | 显示全部楼层
发表于 2025-3-25 09:51:28 | 显示全部楼层
发表于 2025-3-25 14:21:10 | 显示全部楼层
Evaluation of Axillary Nodesreat pathologic response rates, the axilla can become negative in up to 60% of cases, depending on tumor biology. In these cases, SLNB can be performed with low false-negative rates, and the axilla can be saved as in early breast cancer.
发表于 2025-3-25 19:32:34 | 显示全部楼层
发表于 2025-3-25 23:49:03 | 显示全部楼层
http://image.papertrans.cn/b/image/190543.jpg
发表于 2025-3-26 03:54:31 | 显示全部楼层
发表于 2025-3-26 07:28:54 | 显示全部楼层
Volkseinkommen, Löhne und Gewinnessess the prognosis of patients with newly diagnosed breast cancer. In 2009, the seventh revised edition of the TNM system was published to reflect the updates in technology and clinical evidence. Rapid advances in both clinical and laboratory sciences along with translational research have raised q
发表于 2025-3-26 11:50:22 | 显示全部楼层
Makroökonomisches Gleichgewichtast. Ductal carcinoma in situ (DCIS) is characterized by the neoplastic proliferation of epithelial cells confined to the ductal-lobular system of the breast without evidence of invasion through the basement membrane into the surrounding stroma. Most cases of DCIS are positive for estrogen receptor
发表于 2025-3-26 16:36:04 | 显示全部楼层
Eva Below,Wolfram Ebinger,Ulrich Pramannnd schwannoma. Malignant mesenchymal tumors of the breast other than angiosarcomas are extremely rare. However, any type of sarcoma may occur in the breast as a primary lesion, including liposarcoma, leiomyosarcoma, rhabdomyosarcoma, malignant peripheral nerve sheath tumor, and osteosarcoma. Fibroep
发表于 2025-3-26 18:08:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-30 10:21
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表